Pediatric Neurology
Volume 41, Issue 1 , Pages 17-21, July 2009

Proinflammatory Plasma Cytokines in Children With Migraine

  • Leszek Boćkowski, MD

      Affiliations

    • Department of Pediatric Neurology and Rehabilitation, Medical University of Białystok, Białystok, Poland
    • Corresponding Author InformationCommunications should be addressed to: Dr. Boćkowski; Department of Pediatric Neurology and Rehabilitation; Medical University of Białystok; Waszyngton Street 17; 15-274 Białystok, Poland.
  • ,
  • Wojciech Sobaniec, MD

      Affiliations

    • Department of Pediatric Neurology and Rehabilitation, Medical University of Białystok, Białystok, Poland
  • ,
  • Beata Żelazowska-Rutkowska, MD

      Affiliations

    • Department of Pediatric Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland

Received 12 September 2008; accepted 4 February 2009.

Toward understanding the role of cytokines in migraine, this study focused on selected proinflammatory cytokines. The study group consisted of 21 children who had migraine with and without aura; the control group was 24 children with episodic tension-type headache. Plasma interleukin-1α was undetectable in 19 control subjects with tension-type headache, but was detectable in 16 patients with migraine, which suggests that interleukin-1α level might be higher in migraine. Soluble tumor necrosis factor receptor 1 in the migraine group was significantly higher than in the control group (P < 0.0005). Migraine patients tended to have increased tumor necrosis factor α level, compared with the control group. The interleukin-1α level was significantly higher in migraine with aura than in migraine without aura (P < 0.05). Tumor necrosis factor α and soluble tumor necrosis factor receptor 1 levels tended to be increased in the migraine with aura subgroup. The results suggest that proinflammatory cytokines may be involved in the pathogenesis of migraine attacks, although fluctuations in cytokine levels could be different in children than in adults. Such difference could be due to long medical history of migraine in adult patients and frequent intake of analgesic drugs or prophylactic treatment.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(09)00072-1

doi:10.1016/j.pediatrneurol.2009.02.001

Pediatric Neurology
Volume 41, Issue 1 , Pages 17-21, July 2009